Literature DB >> 29464491

Do I Need to Operate on That in the Middle of the Night? Development of a Nomogram for the Diagnosis of Severe Acute Cholecystitis.

Mattia Portinari1,2, Michele Scagliarini3, Giorgia Valpiani4, Simona Bianconcini3, Dario Andreotti5,6, Rocco Stano5,7, Paolo Carcoforo5,6, Savino Occhionorelli5,6,7.   

Abstract

BACKGROUND: Some authors have proposed different predictive factors of severe acute cholecystitis, but generally, the results of risk analyses are expressed as odds ratios, which makes it difficult to apply in the clinical practice of the acute care surgeon. The severe form of acute cholecystitis should include both gangrenous and phlegmonous cholecystitis, due to their severe clinical course, and cholecystectomy should not be delayed. The aim of this study was to create a nomogram to obtain a graphical tool to compute the probability of having a severe acute cholecystitis.
METHODS: This is a retrospective study on 393 patients who underwent emergency cholecystectomy between January 2010 and December 2015 at the Acute Care Surgery Service of the S. Anna University Hospital of Ferrara, Italy. Patients were classified as having a non-severe acute cholecystitis or a severe acute cholecystitis (i.e., gangrenous and phlegmonous) based on the final pathology report. The baseline characteristics, pre-operative signs, and abdominal ultrasound (US) findings were assessed with a stepwise multivariate logistic regression analysis to predict the risk of severe acute cholecystitis, and a nomogram was created.
RESULTS: Age as a continuous variable, WBC count ≥ 12.4 × 103/μl, CRP ≥9.9 mg/dl, and presence of US thickening of the gallbladder wall were significantly associated with severe acute cholecystitis at final pathology report. A significant interaction between the effect of age and CRP was found. Four risk classes were identified based on the nomogram total points.
CONCLUSIONS: Patients with a nomogram total point ≥ 74 should be considered at high risk of severe acute cholecystitis (at 74 total point, sensitivity = 78.5%; specificity = 78.2%; accuracy = 78.3%) and this finding could be useful for surgical planning once confirmed in a prospective study comparing the risk score stratification and clinical outcomes.

Entities:  

Keywords:  Acute cholecystitis; Emergency treatment; Multivariate analysis; Nomogram; Retrospective studies

Mesh:

Substances:

Year:  2018        PMID: 29464491     DOI: 10.1007/s11605-018-3708-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

1.  Distribution of C-reactive protein values in the United States.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

Review 2.  Clinical practice. Acute calculous cholecystitis.

Authors:  Steven M Strasberg
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

Review 3.  A comparison of goodness-of-fit tests for the logistic regression model.

Authors:  D W Hosmer; T Hosmer; S Le Cessie; S Lemeshow
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

Review 4.  Early laparoscopic cholecystectomy is superior to delayed acute cholecystitis: a meta-analysis of case-control studies.

Authors:  Amy M Cao; Guy D Eslick; Michael R Cox
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

5.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  Int J Surg       Date:  2014-07-18       Impact factor: 6.071

6.  Risk factors for acute cholecystitis and a complicated clinical course in patients with symptomatic cholelithiasis.

Authors:  Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Keun Soo Ahn
Journal:  Arch Surg       Date:  2010-04

7.  Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy.

Authors:  L T Merriam; S A Kanaan; L G Dawes; P Angelos; J B Prystowsky; R V Rege; R J Joehl
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

8.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

9.  Prognostic parameters for the prediction of acute gangrenous cholecystitis.

Authors:  Cagatay Aydin; Gülüm Altaca; Ibrahim Berber; Koray Tekin; Melih Kara; Izzet Titiz
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

10.  Use of a predictive equation for diagnosis of acute gangrenous cholecystitis.

Authors:  Liz Nguyen; Shawn P Fagan; Timothy C Lee; Nori Aoki; Kamal M F Itani; David H Berger; Samir S Awad
Journal:  Am J Surg       Date:  2004-11       Impact factor: 2.565

View more
  3 in total

1.  Correlation of Inpatients Suffering from Acute Acalculous Cholecystitis during ICU Treatment with Acute Physiology and Chronic Health Evaluation II Score, Duration of Ventilator Use, and Time on Total Parenteral Nutrition.

Authors:  Yunfeng Zhang; Kaixian Wang; Yuhui Wang; Yang Liu
Journal:  Comput Math Methods Med       Date:  2022-06-30       Impact factor: 2.809

2.  Difficult laparoscopic cholecystectomy and preoperative predictive factors.

Authors:  Giuseppe Di Buono; Giorgio Romano; Massimo Galia; Giuseppe Amato; Elisa Maienza; Federica Vernuccio; Giulia Bonventre; Leonardo Gulotta; Salvatore Buscemi; Antonino Agrusa
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

3.  Patterns of prevalence and contemporary clinical management strategies in complicated acute biliary calculous disease: an ESTES 'snapshot audit' of practice.

Authors:  Gary Alan Bass; Amy Gillis; Yang Cao; Shahin Mohseni
Journal:  Eur J Trauma Emerg Surg       Date:  2020-07-07       Impact factor: 3.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.